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Continuous measurements of renal perfusion in pigs by means perfusion is considered to play a key role [1]. Decreased
of intravascular Doppler. renal perfusion may result from a reduction of mean
Background. Changes in renal blood flow are considered to arterial blood pressure (MABP) or decreased cardiac out-play a significant role in the induction and maintenance of
put or may be due to renal vasoconstriction. The combina-kidney failure, but are difficult to monitor with currently avail-
tion of moderately reduced perfusion pressure and in-able techniques. The objective was to validate renal flow mea-
surements with Doppler guidewires and to apply this technique creased renal vascular resistance (RVR) is believed to
to assess dose and time dependency of the renal vascular effects promote renal failure in patients with sepsis [2] or hepato-
of norepinephrine (NE). renal syndrome [3]. The adverse effects of several “neph-Methods. In 10 anesthetized pigs, flow velocity in renal arter-
rotoxic” agents, including contrast media, on kidneyies (FVart) and veins (FVvein) and volumetric renal blood
function are also considered to be partially due to aflow (VBF) were measured before and after intravenous bolus
application of incremental doses of NE (2 to 200 mg). temporary reduction in RBF [1]. Some studies have indi-
Results. FVart curves exactly reflected the changes in VBF. cated that a reduction in RBF persists during the course
Beat-to-beat analysis revealed a strong linear correlation over of ARF [4, 5], while others have reported that RBF isa mean VBF range of less than 0.05 to 0.35 L/min (median
not an important determinant of the glomerular filtrationcorrelation coefficient with FVart, r 5 0.998), and significant
rate (GFR) depression during the maintenance phase ofbut less close relationships were also found between VBF and
FVvein. Ten seconds after the administration of 200 mg NE, postischemic ARF [6, 7]. Therefore, in different clinical
FVart dropped from 71 to 6 cm/sec and was 90% reversible situations, monitoring of renal perfusion may be rele-
after 48 seconds. Similarly, the renal vascular resistance tempo-
vant, not only to characterize further the associationrarily rose from 988 to 13711 mm Hg · min/L. In contrast,
between changes in renal hemodynamics and GFR, butNE-induced increases in systemic vascular resistance were on
average a maximum of 1.5-fold but persisted for more than 60 also to identify and prevent ischemic insults to the
seconds. kidney.
Conclusions. Doppler flow measurements in the renal artery Currently available methods for the measurement of
provide an excellent surrogate of volumetric blood flow, which
RBF in humans have been useful to detect RBF abnor-may be useful for continuous monitoring of renal hemodynam-
malities in various settings, but are characterized by sev-ics. The renal vasculature is more sensitive when compared
with the systemic vasculature, but also appears to evoke more eral methodological problems that limit their accuracy
efficient counter-regulatory mechanisms in response to NE. and applicability. The urinary clearance of p-aminohip-
purate (PAH) [8] cannot be applied to oligo-anuric sub-
jects, and in postischemic renal failure, PAH extraction
A reduction in renal blood flow (RBF) commonly is severely impaired so that the PAH clearance markedly
occurs in association with renal dysfunction and can cause underestimates renal plasma flow [6]. Dye dilution tech-
kidney failure. In acute renal failure (ARF), renal hypo- niques require the simultaneous catheterization of the
renal artery and vein and allow only bolus measurements
[9]. For isotope techniques, the need for external count-Key words: renal blood flow, Doppler guide wire, norepinephrine,
volumetric blood flow, monitor hemodynamics. ing devices limits their bedside use. Moreover, the renal
uptake of commonly used radiopharmaceuticals, suchReceived for publication June 20, 2000
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port in ARF [6]. Electron beam computer tomography METHODS
is a noninvasive method that has a good potential to The study protocol was approved by the state author-
measure not only blood flow, but distribution of blood ity responsible for animal experiments (authorization
flow within the renal parenchyma [10]. However, it also code: G0353/98) and conforms to the principles of the
does not allow more prolonged monitoring and requires American Physiological Society and the American Heart
contrast media. Thermodilution catheters have been Association.
used to measure blood flow in renal veins [11, 12], but
complete turbulent mixing of injectate and blood in the Animals and instrumentation
renal vein requires injection rates of up to 100 mL/min Ten female country pigs (weight range of 24 to 31 kg)
[12]. Transcutaneous Doppler flow measurements are were studied. They were anesthetized by intravenous
noninvasive and have a much better time resolution than thiopental sodium (10 mg/kg) after taking nothing by
the techniques mentioned previously in this article [5, mouth for at least 12 hours. Atropine (0.05 mg/kg) and
13, 14]. However, this method determines only relative azaperon (4 to 5 mg/kg, Stresnilt) were given intramus-
changes in flow indices, which have not been validated cularly 30 minutes prior to anesthesia, and etomidate
against absolute flow measurements. In addition, trans- (2.5 to 3.5 mg/kg intravenously) was used for sedation.
abdominal duplex sonography is observer dependent, An 18-gauge intravenous line was placed in auricular
and in situations in which patients are at risk of devel- veins of both ears for continuous infusion of etomidate
oping ARF, the conditions are far from optimal. Volu- (at 0.7 to 1.0 mg/kg/hour) and fentanyl (at 0.025 mg/kg/
metric blood flow measurements that use a flow probe hour). Repetitive doses of Pancuroniumt 4 mg were
attached to the outer vessel circumference provide accu- given intravenously as necessary to prevent spontaneous
rate and continuous estimates of RBF, but in humans, movement. The trachea was intubated with a Hi-Lo
this technique can only rarely be applied under very cuffed endotracheal tube with an interior diameter of
selected circumstances [6]. 7.0 to 8.0 mm (Mallinckrodt Medical Ó , Athlone, Ireland).
In view of these limitations, we have decided to evalu-
A constant-volume ventilator (Servo Ventilator 900 D,
ate the potential usefulness of intravascular Doppler flow
Siemens Elena Ó , Sweden) accomplished ventilation at ameasurements, which use a guidewire with a Doppler
tidal volume of 10 to 15 mL/kg. Enriched inspired O2transducer mounted at the tip, as a novel approach for
[fraction of inspired oxygen (Fio2)] 40% and NO2 werecontinuous and prolonged monitoring of renal perfusion.
given, and arterial blood gases (ABL TM 505; Radiome-The use of Doppler guidewires for blood flow velocity
terÓ , Copenhagen, Denmark), potassium, and hemoglo-measurements has been established in coronary diagnos-
bin concentrations (OSMe Hemoximeter, Radiometer Ó ,tic procedures and provides an excellent surrogate mea-
Copenhagen, Denmark) were periodically monitored.surement of volumetric coronary flow [15]. A close corre-
Changes in ventilatory frequency were made as neces-lation between flow velocity determined by intravascular
sary to maintain an arterial Paco2 of between 38 and 42Doppler guidewire and volumetric blood flow has also
mm Hg and an arterial pH of between 7.37 and 7.42. Abeen shown in the carotid artery of pigs [16]. Recently,
standard lead II electrocardiogram was used to monitorthe feasibility of using intravascular Doppler technology
the heart rate.in renal arteries has been demonstrated in pigs [17] and
Saline filled sheaths were introduced to both femoralin humans under resting conditions [18] and after angi-
arteries (6.5 French) and veins (8.5 French) using theoplasty [19]. However, the relationship between flow
Seldinger technique after surgical preparation of the ves-velocity and absolute blood flow in renal vessels has not
sels. To avoid blood loss from the vessel puncture sites,been investigated. If such a relationship is sufficiently
the sheaths were secured by normal adaptation with 3 mmclose, flow velocity measurements might be useful to
Mersilenet strings. A saline-filled 5 French polyethyleneassess changes in renal perfusion under experimental
catheter was advanced into the abdominal aorta fromand selected clinical circumstances.
the right femoral arterial sheath for the measurement ofThis preclinical study was therefore performed to eval-
ABP. A saline-filled 7.5 French Swan-Ganz continuousuate the level of correlation between flow velocity mea-
cardiac output (CCO)/oximetry thermodilution cathetersurements in renal arteries and veins of pigs with volu-
(Baxter Healthcare Corporation Ó , Irvine, CA, USA) wasmetric RBF as measured by extravascular Transonic flow
inserted through the right venous sheath and advanced,probes. Applying this technique, we have studied time-
flow-directed into the right atrium and right pulmonaryand concentration-dependent changes in renal perfusion
artery. The placement of the catheter in the pulmonaryafter the administration of norepinephrine (NE). This
artery was verified by x-ray study.a-adrenergic catecholamine is widely used to maintain
The right renal artery was isolated after median lapa-perfusion pressure in shock syndromes [20], but contro-
rotomy and a 4-mm ultrasonic flow probe (2.4 MHz;versial evidence exists about its effects on renal hemody-
namics. Transonic SystemsÓ , Ithaca, NY, USA) was placed around
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it to measure volumetric renal blood flow (VBF). The gration was developed. This software runs on a standard
flow probe was fixed in place and sutured at the retroperi- laptop computer (TECRA 8000; ToshibaÓ Europe, Neuss,
toneum for stability, and the connecting cable was led Germany; Pentiumt II, 300 MHz processor) and allows
out through a small lateral cut in the abdominal skin. sampling at a rate of up to 1 kHz. The data acquisition
Ultrasonic gel was placed around the flow probe to mini- software MODA 2.0 were compiled by the use of the
mize movement artifacts and to improve the acoustic Borland C11 Builder V4 Professional (Inprise Corpora-
signal. The abdomen was closed with interrupted sutures. tion Ó , Scotts Valley, CA, USA), which enables the re-
All animals received a 0.9% saline infusion at a flow rate cording and display of up to eight analog channels simul-
of 10 mL/kg/hour. Additional volume (saline 0.9 or 6% taneously. Interfacing (connection) of the different analog
hydroxy-ethyl-starch solution) was infused to maintain devices was realized by BNC cable to an input connector
the central venous pressure at between 5 and 10 mm Hg. box, which was connected to a PCMCIA analog/digital
A 4 French multipurpose guiding catheter (Tempoe board (PCM-DAS16/16e; Computer Boards, Inc. Ó , Mid-
Cobra 1; CordisÓ , Waterloo, Belgium) was directed from dleboro, MA, USA) inside the laptop. Cardiac output,
the left femoral arterial sheath into the right renal artery. body temperature, and central venous saturation were
This catheter nearly occluded the vessel. A 0.018 inch transmitted via a serial port cable from the Vigilance
(0.46 mm) Doppler guidewire (FloWiret; Cardiometrics Monitor. For the purpose of postprocessing analysis of
Inc.Ó , Mountain View, CA, USA) was introduced through the data MATLAB V5.3 (Scientific ComputersÓ , Aachen,
the guiding catheter into the renal artery and placed Germany) scripts were employed. These scripts were
under x-ray control precisely at the position of the flow used to calculate the time integrals of flow, flow velocity,
probe. This catheter carried a 12 MHz pulsed wave and pressure for each heart beat. The difference between
Doppler probe with a sample volume of 5.2 mm to mea- average peak velocity (APV) provided by the FloMap Ó
sure renal artery flow velocity (FVart). The Doppler and the calculated flow-velocity integral is only related
catheter was connected with a FloMapt ultrasound ma- to the integration time, which is two heart beats or two
chine (Cardiometrics, Inc.Ó ). After the Doppler guidewire seconds in the Cardiometrics Ó device. Further scripts
placement, the guiding catheter was drawn back into the were employed for creating diagrams showing flow, flow
aorta. This procedure was completed in less than 60 sec- velocity, and pressure curves for individual as well as all
onds to avoid ischemic kidney damage caused by the 10 pigs. The resulting values were saved in ASCII format
decrease of blood flow induced by the guiding catheter. and further calculations were performed using Excel 97
A 5 French multipurpose catheter (Tempoe Cobra 1; (Microsoft Ó ) software (discussed later in this article).
CordisÓ ) was directed from the left femoral venous
sheath into the right renal vein under x-ray control. An- Experimental protocol
other 0.018 inch Doppler guidewire was introduced in
The animals were prepared as described previously inthe renal vein to measure renal venous flow velocity
this article. Baseline values and calibration signals were(FVvein). As the renal vein lumen in pigs is much larger
recorded first. NE (Hoechst Ó , Frankfurt/Main, Ger-than the renal artery lumen, the renal vein catheter was
many) was administered intravenously as a 2 to 5 mLleft in place to improve the Doppler guidewire placement
bolus in saline via the femoral venous sheath. The NEin the middle of the vessel and to minimize wall and
dose was increased by the following steps: 2 mg, 10 mg,movement artifacts.
5 times then 20, 50, 100, and 200 mg. Data that includedThe vascular catheters were connected to low-displace-
the renal artery flow velocity, and in parallel VBF, werement transducers (disposable transducer DT-XX; Bec-
recorded after injection of the bolus until renal flow hadton Dickinson Ó , Heidelberg, Germany). The reference
returned to baseline values. The NE application waspoint for all vascular pressures was the midcardiac plane.
repeated to assess the renal venous flow velocity.Heart rate, blood, central venous and pulmonary ar-
At the conclusion of the experiment, the animals weretery pressures were displayed on a standard Hewlett
killed by intravenous injection of KCl.Packard patient monitor (M104AIB; HP Ó , McMinnville,
OR, USA). Continuous cardiac output and mixed ve-
Statistical analysis and calculationsnous oxygen saturation (Svo2) data and blood tempera-
Data are displayed as medians and 25th/75th percen-tures were displayed on a Vigilance Monitor (Baxter
tiles. Linear correlation coefficients (Pearson) were cal-Healthcare Corporation).
culated for the comparison of VBF and renal flow veloc-
Online registration software development and ity (mean velocity calculated over one cardiac cycle;
postprocessing data analysis discussed previously in this article). The Kruskal–Wallis
test was used to calculate significance in a series of mea-To enable online waveform comparison and postpro-
surements (Table 1). RVR was calculated using this for-cessing beat-to-beat comparison of flow and velocity
curves, special software for multiple signal source inte- mula:
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Table 1. Effect of five repetitive applications of norepinephrine 20 mg on renal arterial flow velocity (intra-arterial flow wire) in eight pigs
Application no. 1 2 3 4 5 P value
FVartmin cm/sec 18.1 16.5 19.3 19.5 23.1 0.985
6.8/34.4 7.0/31.2 5.7/29.1 9.2/28.2 5.2/31.7
tmin sec 10.0 10.5 10.0 10.5 10.5 0.991
9.3/12.3 9.0/12.8 8.3/13.3 9.0/13.8 9.0/13.0
t90% sec 29.5 27.5 32.0 32.0 30.5 0.860
26.8/39.0 25.5/35.3 27.5/37.5 24.3/36.5 28.3/35.8
Values are medians and 25%/75% percentiles. Abbreviations are: FVartmin, minimum renal arterial flow velocity after the application of norepinephrine (NE)
20 mg intravenously; tmin, time interval until minimum FVart was reached after application of NE; t90%, time at which renal blood flow reduction returned to 90% of
baseline. P values are from the Kruskal-Wallis test.
ABP with a frequency of approximately 14 per minute
RVR [mm Hg · min/L] 5
MABP 2 CVP
VBF were respiration associated and led to parallel cyclic
changes in renal perfusion (Fig. 1A).
where VBF is the mean volumetric renal blood flow Figure 1A depicts the parallel recording of ABP, VBF,
(L/min), MABP is the mean aortic blood pressure and FVart following the bolus application of NE 20 mg
(mm Hg), and CVP is the central venous pressure at zero time. It can be seen that this resulted in an
(mm Hg). increase in heart rate and a rise in blood pressure after
Systemic vascular resistance (SVR) was calculated us- approximately five seconds, and a rapid decline in renal
ing this formula: perfusion after approximately eight seconds. The reduc-
tion in renal perfusion resulted in a brief cessation of
SVR[mm Hg · min/L] 5
MABP 2 CVP
CO diastolic flow, but this was completely reversible approxi-
mately 30 seconds after the injection. In contrast, the
where CO is the cardiac output (L/min). elevation in ABP persisted for approximately two min-
Diagrams were drawn by the use of Excel 97t (Micro- utes. This effect of NE was highly reproducible in the
soft Ó Corporation, Redmond, WA, USA) and Matlabt cohort. The time course of changes in VBF, FVart, RVR,
V5.3 (Scientific Computers Ó , Aachen, Germany) soft- systemic vascular resistance (SVR), and MABP in all 10
ware. animals are summarized in Figure 2. The effect of NE
In Figure 2, the mean values of one cardiac cycle on the systemic vasculature lasted longer when com-
every five seconds of each animal were used to calculate pared with the renal vessels (Fig. 2, D and E).
median and interquartile range of values. When the effect of incremental doses of NE was tested,
a temporary reduction of renal perfusion was observed
over the entire dose range that was investigated (2 toRESULTS
200 mg). With an increasing dose of NE, both the extentThe placement of extravascular flow probes and intra-
and duration of reduction in RBF increased. This isvascular Doppler flow guidewires in the renal arteries and
shown in Figure 3A, which illustrates median renal arte-veins was easily established in all animals investigated.
rial flow velocity in 10 pigs 10 and 25 seconds after bolusUnder baseline conditions median (25th/75th percen-
applications of NE. RVR 10 seconds after bolus applica-tiles) VBF was 142 mL/min (116/152, 5.3 mL/kg/minute,
tion, as calculated from VBF and mean arterial pressure,4.1/6.0, N 5 10). These values corresponded to median
was exponentially related to NE dose and increased byFVart of 81 cm/sec (50/101, N 5 10). FVvein was approxi-
up to 14-fold (Fig. 3C). After the maximum dose of NEmately 10 times lower, and the median value was 8.3 cm/sec
(200 mg), RVR increased from baseline (988 mm Hg ·(7.0/11.8, N 5 8).
min/L) to a maximum value of 13711 mm Hg · min/L 10Under all conditions investigated, changes in VBF
seconds after intravenous NE application (Fig. 3C).were paralleled by changes in FV. As demonstrated in
To test for possible changes in renal vascular respon-initial recording (Fig. 1A), simultaneously registered
siveness to NE, repetitive bolus applications of NE 20 mgcurves of VBF and FVart were superimposed and virtu-
were given to each animal after time intervals of two toally indistinguishable from each other, unless the time
five minutes. As shown in Table 1, NE effects were highlyscale was stretched (Fig. 1B). The slight phase displace-
reproducible and did not change with time. When com-ment of the trace of ABP of approximately 0.3 of a
paring FV measurements in the renal artery and vein,second, which became apparent with a change of scale
parallel changes were observed under all conditions in-of the time axis in Figure 1B, was due to the travel time
vestigated and both arterial and FVvein correlated withof the pulse wave in the fluid filled systems that were
used for blood pressure recordings. Cyclic alterations of VBF. As an example, the upper panel of Figure 4 shows
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Fig. 1. Original recording of arterial blood pressure (ABP), renal arterial flow velocity (FVart), and volumetric renal blood flow (VBF) following
the application of norepinephrine (NE) 20 mg at zero time. As the flow and the velocity curve are superimposed (A), in (B) the time scale was
increased to show the beat-to-beat comparison of the variables at higher resolution.
Fig. 2. Time course of volumetric renal blood flow (VBF), renal arterial
flow velocity (FVart), renal vascular resistance (RVR), systemic vascu-
lar resistance (SVR), and mean arterial blood pressure (MABP) follow-
ing the application of NE 20 mg in 10 animals (median and interquartile
range). RVR was calculated from the pressure difference (MABP-
central venous pressure) and VBF. SVR was calculated from the pres-
sure difference (MABP-central venous pressure) and cardiac output, as
measured with a Swan-Ganz continuous cardiac output thermodilution
catheter.
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investigated (Table 2). When comparing the relationship
between arterial and venous FV measurements and VBF
(Fig. 4), it became obvious that flow velocity in the vein
is in the range of values in which the correlation is less
optimal (that is, below 15 cm/sec). Thus, although
FVvein and (arterial) VBF were still significantly corre-
lated, median correlation coefficients between flow and
velocity were always lower than in the renal artery, and
the variation between animals was greater (Table 2).
DISCUSSION
This study shows that the insertion of Doppler flow
guidewires into the main renal vessels enables continu-
ous monitoring of renal perfusion and provides an easy
way to accurately detect and quantitate changes in RBF.
Although a significant correlation between VBF and FV
could be demonstrated in the renal vein, the much closer
relationship between VBF and FVart favors the use of
Doppler guidewires primarily in the arterial system. Im-
portantly, FVart was linearly related to VBF over a
broad range of values, even to as low as one seventh of
the baseline flow rate. It appeared to become somewhat
less accurate only with flow rates below 50 mL/min. Since
the relationship between total RBF and FV depends on
the size of the renal artery, these results may not be
directly extrapolated to humans. However, when related
to body weight, renal hemodynamics in pigs is similar
to those of humans [21]. Previous studies have found
flow velocities of up to 60 cm/sec (peak systolic velocity,
which corresponds to an APV of ,30 cm/sec) in nonste-
notic human renal arteries [22]. These values in human
renal arteries fit well within the linear range established
in our experiments.
In contrast to transabdominal ultrasound, the tech-
nique is invasive and if applied to renal arteries may
Fig. 3. Dose dependency of the effect of norepinephrine (NE) on renal theoretically create vasospasm and damage to the endo-
arterial flow velocity (FVart, A), mean arterial blood pressure (MABP, thelium. However, given the small dimensions of theB), and renal vascular resistance (RVR, C). RVR was calculated from
guide wire and its flexibility, we believe that the risksrenal artery flow (extravascular flow probe) and the pressure difference
(MABP-central venous pressure). Symbols are: (d) values 10 seconds are small. Under selected circumstances, the technique
after the application of NE; (s) values 25 seconds after the application therefore warrants further careful evaluation. Particu-of NE. Note that the reduction in FVart was partially reversible after
larly in patients in whom other hemodynamic parameters25 seconds, although the MABP tended to be higher than after 10
seconds. are already invasively monitored and who are at a pre-
dictable risk for developing renal dysfunction, such as
patients undergoing cardiac surgery [23], this technique
may reveal information about the changes in renal hemo-the correlation between blood flow and FVart in one
dynamics that cannot be obtained with any other methodanimal using values that were recorded during the appli-
previously used to measure RBF in humans. In addition,cation of different doses of NE. While the relationship
the efficacy of certain drugs that have been shown towas continuously linear above a RBF of 0.05 L/min, it
ameliorate renal perfusion in animal experiments, suchtended to flatten with lower blood flow rates. Similar
as endothelin antagonists [24], could be directly assessedrelationships were found in all of the animals. The regres-
in humans. In brain-dead organ donors, the monitoringsion curves were not exactly superimposed due to inter-
of renal perfusion might be helpful to guide supportiveindividual variability of the renal artery diameter. In all
therapy toward an optimal preservation of renal func-animals, however, the correlation coefficients between
FVart and VBF were close to 1.0 under all conditions tion. For such indications, the fact that only relative
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Fig. 4. Correlation of volumetric renal blood
flow (VBF) and flow velocity in one experi-
mental animal (using data obtained for all NE
doses). Correlation with (A) renal arterial flow
velocity (FVart) and (B) renal venous flow
velocity (FVvein). Because of the larger diam-
eter of the renal vein, the renal venous flow
velocity is approximately 10 times lower. Cor-
relation coefficients for all animals investi-
gated are listed in Table 2.
Table 2. Correlation coefficients between simultaneous measurements of volumetric renal blood flow (extravascular flow probe) and arterial
or venous blood flow velocity (intravascular Doppler guide wire) following the application of increasing doses of norepinephrine in 10 pigs
2 mg NE 10 mg NE 20 mg NE 50 mg NE 100 mg NE 200 mg NE
Arterial flow velocity
Median 0.98 0.98 1.00 0.99 0.99 0.99
(Min–max) (0.55–1.00) (0.88–1.00) (0.95–1.00) (0.91–1.00) (0.95–1.00) (0.73–1.00)
Venous flow velocity
Median 0.51 0.66 0.81 0.86 0.89 0.80
(Min–max) (20.09–0.92) (20.32–0.90) (20.08–0.89) (0.35–0.88) (0.37–0.92) (0.33–0.88)
Data are Pearson correlation coefficients. Abbreviations are: Min, minimum; max, maximum; NE, norepinephrine intravenously.
changes in perfusion can be detected by flow velocity reductions related to renal artery stenosis because of the
existence of turbulent movement.measurements is not a significant limitation. Moreover,
if information about “absolute” flow rates is required, Some of the advantages of the flow wire technique,
combined with other hemodynamic measurements, havethis can be calculated by combining flow velocity re-
cordings with a technique that gives an approximate esti- been shown in this study by assessing the effects of NE
on RBF. NE is an a-adrenergic catecholamine that hasmate of the cross-sectional area of the vessel. This is
possible with intravascular ultrasound (IVUS), which is previously been shown to reduce RBF after intra-arterial
injection [25, 26]. NE-induced renal ischemia has beenfrequently used in coronary arteries, in combination with
Doppler ultrasound and by angiography [17, 18]. Such used as a model for ARF in rats [27] and dogs [28].
However, the effects of NE on the renal vasculaturecalculated “absolute” flow rates may, however, overesti-
mate the RBF because of the laminar flow profile. It after systemic (intravenous) application are less clear.
Several studies reported that RBF may be enhanced byshould be noted that close correlations between flow and
velocity found in the present study during vasoconstric- NE in healthy animals [29, 30], and in models of endo-
toxin shock, the RBF was reported to be enhanced aftertion of small renal arteries may not be true for flow
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NE infusion [31]. In critically ill patients, the efficacy APPENDIX
[32–34] and safety [35, 36] of NE in treating refractory Abbreviations used in this article are: ABP, arterial blood pressure;
hypotension in septic shock has been demonstrated, but APV, average peak velocity; ARF, acute renal failure; CCO, continu-
ous cardiac output; FIO2, fraction of inspired oxygen; FVart, flowknowledge about its visceral vasoconstriction properties
velocity in renal arteries; FVvein, flow velocity in renal veins; GFR,has raised concerns about the advisability of its sustained glomerular filtration rate; IVUS, intravascular ultrasound; NE, norepi-
infusion in hemodynamically unstable patients. nephrine; NO, nitric oxide; PAH, para-aminohippurate; RBF, renal
blood flow; RVR, renal vascular resistance; SvO2, oximetry; SVR, sys-Part of the discrepancy of the effects of intrarenal
temic vascular resistance; VBF, volumetric blood flow.arterial and systemic application of NE on RBF may
theoretically result from the elevation of arterial perfu-
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